India metronidazole market?

See the DrugPatentWatch profile for metronidazole

India's Metronidazole Market

Metronidazole is a widely used antimicrobial drug, and India plays a significant role in its global production and consumption. The market dynamics in India are influenced by factors such as the prevalence of infectious diseases, regulatory policies, and the presence of numerous domestic pharmaceutical manufacturers.

Why is Metronidazole Important in India?
Metronidazole is a crucial medication for treating a range of infections caused by anaerobic bacteria and certain parasites [1]. Its effectiveness against conditions like amoebiasis, giardiasis, and bacterial vaginosis makes it a staple in Indian healthcare. The drug is available in various formulations, including tablets, injections, and topical preparations, catering to diverse treatment needs [2].

Who Manufactures Metronidazole in India?
Numerous Indian pharmaceutical companies produce metronidazole, contributing to both the domestic supply and export markets. Companies like Cadila Pharmaceuticals, Abbott India, and IPCA Laboratories are among those involved in the manufacturing and distribution of metronidazole-based products [3][4][5]. The competitive landscape among these manufacturers influences pricing and availability.

When Might Metronidazole Patents Expire?
Metronidazole is a well-established drug with generic availability in India. Patents for older, off-patent drugs like metronidazole have long since expired, allowing for widespread generic production [6]. This lack of patent protection is a key reason for its affordability and accessibility in the Indian market. For specific product formulations or novel delivery methods, however, patent information would need to be individually assessed. DrugPatentWatch.com is a resource for tracking such patent expirations.

What Are the Price Trends for Metronidazole in India?
Due to the generic nature of metronidazole, its pricing in India is generally low. The presence of multiple manufacturers and the absence of patent exclusivity contribute to a competitive market, keeping costs down for consumers and healthcare providers [6]. Prices can vary slightly between brands and formulations, but overall affordability is a defining characteristic of its market.

How Does Metronidazole Compare to Other Antibiotics?
Metronidazole is specifically effective against anaerobic bacteria and protozoa, differentiating it from broad-spectrum antibiotics that target a wider range of bacteria [1]. While other antibiotics may be used for different types of infections, metronidazole remains a first-line treatment for many parasitic and anaerobic bacterial conditions prevalent in India.

What Are the Regulatory Considerations for Metronidazole in India?
Metronidazole is regulated by the Central Drugs Standard Control Organization (CDSCO) in India [7]. Manufacturers must adhere to stringent quality control and manufacturing practices to ensure the safety and efficacy of their products. The availability of metronidazole in different strengths and forms is approved by regulatory authorities for specific medical indications.

Sources:
1. National Center for Biotechnology Information (NCBI). Metronidazole. https://www.ncbi.nlm.nih.gov/books/NBK540097/
2. IndiaMART. Metronidazole. https://www.indiamart.com/proddetail/metronidazole-injection-19889698155.html
3. Cadila Pharmaceuticals. https://www.cadilapharma.com/
4. Abbott India. https://www.abbott.com/corpnewsroom/companies/abbott-in-india.html
5. IPCA Laboratories. https://www.ipca.com/
6. DrugPatentWatch.com. https://drugpatentwatch.com/
7. Central Drugs Standard Control Organization (CDSCO). https://cdsco.gov.in/